MUC5AC and colitis: Preclinical investigations utilizing models such as dextran sulphate sodium (DSS)-induced colitis and cyclophosphamide (CTX)-induced immunosuppression have demonstrated the capacity of these peptides to restore gut barrier integrity by reinstating the expression of tight junction proteins (ZO-1, occludin) and enhancing mucin production.